Related content

Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling

By Thrane Susan  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 71-80

Springer Publishing Company

Access to resources Recommend Favorite

Dose-dependent effect of tamoxifen in tamoxifen-resistant breast cancer cells via stimulation by the ERK1/2 and AKT signaling pathways

By                  

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1563-1569

Spandidos Publications

Access to resources Recommend Favorite

Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluorouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells

By Kurebayashi Junichi   Nukatsuka Mamoru   Nagase Hideki   Nomura Tsunehisa   Hirono Mai   Yamamoto Yutaka   Sugimoto Yoshikazu   Oka Toshinori   Sonoo Hiroshi  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 4, 2007-03 ,pp. : 515-525

Springer Publishing Company

Access to resources Recommend Favorite

Phosphorylation of estrogen receptor α at serine 118 is correlated with breast cancer resistance to tamoxifen

By          

Oncology Letters, Vol. 6, Iss. 1, 2013-01 ,pp. : 118-124

Spandidos Publications

Access to resources Recommend Favorite

Activation of mitogenic pathways and sensitization to estrogen-induced apoptosis: two independent characteristics of tamoxifen-resistant breast cancer cells?

By Scherbakov Alexander   Lobanova Yulia   Shatskaya Valentina   Onopchenko Oksana   Gershtein Elena   Krasil’nikov Mikhail  

Breast Cancer Research and Treatment, Vol. 100, Iss. 1, 2006-11 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite